pyrotinib,blinatumomab
jiangsu hengrui pharmaceuticals,astellas pharmaceuticals,amgen
['leusm', 'blinatumomab', 'leukemia', 'irene']
congress #eha22 | irene urbino from aou citt della salute e della scienza di torino presented the efficacy results from an rwe study of blinatumomab given as consolidation in adults with b-all. n=20, complete mrd-response: 83% in cr1 pts &amp; 86% in cr2 pts #allsm #leusm #leukemia 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm